CareDx Inc (CDNA)
NASDAQ: CDNA
· Real-Time Price · USD
13.53
0.00 (0.00%)
At close: Sep 12, 2025, 3:59 PM
13.53
0.00%
After-hours: Sep 12, 2025, 05:42 PM EDT
0.00% (1D)
| Bid | 13.2 |
| Market Cap | 720.16M |
| Revenue (ttm) | 340.83M |
| Net Income (ttm) | 51.68M |
| EPS (ttm) | 1.05 |
| PE Ratio (ttm) | 12.89 |
| Forward PE | -95.21 |
| Analyst | Buy |
| Ask | 14 |
| Volume | 829,793 |
| Avg. Volume (20D) | 1,659,066.9 |
| Open | 13.40 |
| Previous Close | 13.53 |
| Day's Range | 13.23 - 13.71 |
| 52-Week Range | 10.96 - 32.97 |
| Beta | 2.28 |
About CDNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CareDx Inc is scheduled to release its earnings on
Nov 3, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+10.67%
CareDx shares are trading higher after the company...
Unlock content with
Pro Subscription
7 months ago
+11.16%
CareDx shares are trading higher after Chevy Chase Trust CIO Amy Raskin disclosed on CNBC's Halftime Report that she has bought the stock.
1 month ago · fool.com
CareDx (CDNA) EPS Beats Sales Gain 14%CareDx (CDNA) EPS Beats Sales Gain 14%
1 month ago · businesswire.com
CareDx Announces Appointment of Nathan Smith as Chief Financial OfficerBRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinica...
